Valuation: Alkem Laboratories Limited

Market Cap 637B 6.67B 5.83B 5.48B 5B 9.38B 9.38B 65.73B 25.36B 326B 25.04B 24.49B 1,049B P/E 2027 *
27.8x
P/E 2028 * 24.2x
Enterprise Value 624B 6.53B 5.71B 5.36B 4.9B 9.19B 9.19B 64.38B 24.84B 319B 24.53B 23.99B 1,028B EV / Sales 2027 *
3.74x
EV / Sales 2028 * 3.28x
Free-Float
37.56%
Yield 2027 *
0.93%
Yield 2028 * 1.04%
1 day-0.24%
1 week+4.87%
Current month-0.30%
1 month-1.12%
3 months-0.70%
6 months+1.51%
Current year-3.05%
1 week 5,149.45
Extreme 5149.45
5,501.6
1 month 5,052.05
Extreme 5052.05
5,501.6
Current year 5,052.05
Extreme 5052.05
5,933
1 year 5,052.05
Extreme 5052.05
5,933
3 years 3,440.05
Extreme 3440.05
6,440
5 years 2,835
Extreme 2835
6,440
10 years 1,400
Extreme 1400
6,440
Manager TitleAgeSince
President - -
President - -
Director of Finance/CFO - 31/01/2024
Director TitleAgeSince
Director/Board Member 44 08/08/2013
Director/Board Member 63 10/02/2008
Director/Board Member 45 10/11/2019
Change 5-day change 1-year change 3-year change Capi.($)
-0.24%+4.87% - - 6.69B
+0.45%+3.00%+55.00%+112.54% 1,038B
-0.10%+0.74%+54.52%+67.72% 649B
+0.28%+0.82%+19.15%+73.63% 467B
-0.19%+0.97%+34.30%+45.99% 355B
+0.28%+2.30%+18.47%+26.67% 269B
+0.89%+4.26%+12.10%+16.41% 260B
+4.34%+9.21%+43.44%+53.25% 213B
-0.46%-6.20%-32.46%-59.65% 176B
+1.40%+4.35%+35.72%+103.53% 187B
Average +0.63%+1.04%+26.69%+48.90% 401.68B
Weighted average by Cap. +0.47%+1.47%+36.49%+67.26%

Financials

2027 *2028 *
Net sales 167B 1.75B 1.53B 1.43B 1.31B 2.46B 2.46B 17.22B 6.64B 85.28B 6.56B 6.42B 275B 186B 1.94B 1.7B 1.6B 1.46B 2.73B 2.73B 19.15B 7.39B 94.84B 7.3B 7.14B 306B
Net income 23.14B 242M 212M 199M 181M 341M 341M 2.39B 921M 11.82B 909M 889M 38.1B 27.15B 284M 248M 233M 213M 400M 400M 2.8B 1.08B 13.87B 1.07B 1.04B 44.7B
Net Debt -13.08B -137M -120M -112M -103M -192M -193M -1.35B -520M -6.68B -514M -503M -21.53B -28.06B -294M -256M -241M -220M -413M -413M -2.89B -1.12B -14.33B -1.1B -1.08B -46.19B
Logo Alkem Laboratories Limited
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
Employees
19,346
Date Price Change Volume
22/09/26 ₹5,337.15 -0.24% 805
21/09/26 ₹5,350.00 -2.76% 3,638
18/09/26 ₹5,501.60 +3.03% 25,104
17/09/26 ₹5,340.00 +2.91% 5,586
16/09/26 ₹5,188.95 +0.66% 53,758
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
5,331.50INR
Average target price
5,948.55INR
Spread / Average Target
+11.57%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!